PSYCHIATRIC EPIDEMIOLOGY AND BURDEN OF DISEASE
The core aim of Psychiatric Epidemiology and Burden of Disease (PEABOD) Group is to estimate the global distribution, risk factors, outcomes, and burden of mental and substance use disorders.
This group holds one the largest global epidemiological datasets for mental and substance use disorders, with these datasets updated yearly. PEABOD is also the only research group outside the Institute for Health Metrics and Evaluation (IHME) at the University of Washington to operate as core working members in the Global Burden of Disease Study (GBD) and has a formal arrangement with IHME to undertake the estimation of all burden of disease estimates for mental and substance use disorders featured in the yearly iterations of GBD.
PEABOD has many established and ongoing research collaborations with Australian and overseas institutions and organisations, including the World Health Organisation. The group also provides expert advice to State and Commonwealth Governments, as well as national and international stakeholders, regarding the epidemiology and burden of mental and substance use disorders.